§ 315.3. General factors relevant to safety and effectiveness.
60 words·~1 min read·
/us/cfr/t21/s§ 315.3·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
FDA's determination of the safety and effectiveness of a diagnostic radiopharmaceutical includes consideration of the following:
(a)The proposed use of the diagnostic radiopharmaceutical in the practice of medicine,
(b)The pharmacological and toxicological activity of the diagnostic radiopharmaceutical (including any carrier or ligand component of the diagnostic radiopharmaceutical), and
(c)The estimated absorbed radiation dose of the diagnostic radiopharmaceutical.